Literature DB >> 21307767

Inflammation confers dual effects on nociceptive processing in chronic neuropathic pain model.

Jiin-Tarng Liou1, Fu-Chao Liu, Chih-Chieh Mao, Ying-Shu Lai, Yuan-Ji Day.   

Abstract

BACKGROUND: Although inflammation induces pain, immune cells also produce mediators that can effectively counteract it. To further elucidate the role of the immune response, we analyzed the relationship of pain behavior, several inflammatory signals, and opioid peptides using partial sciatic nerve ligation in mice at different levels of immunocompromise.
METHODS: Sciatic nerves of C57BL/6C, nonobese diabetic (NOD), or nonobese diabetic-severe combined immune deficiency (NOD-SCID) mice were partially ligated. Responses to mechanical and radiant heat stimuli were observed. Inflammation was detected by immunohistochemistry and flow cytometry. Inflammatory cytokines and opioid peptides were analyzed using real-time polymerase chain reaction and enzyme-linked immunosorbent assay or immunostaining.
RESULTS: Inflammation in immunocompromised mice was subordinate when compared with that seen in C57BL/6C mice. In addition, immunocompromised mice had less pain hypersensitivity at early stages. Whereas proinflammatory tumor necrosis factor-α (TNF-α), interleukin 1β (IL-1β), interleukin 6 (IL-6), and interferon-γ (IFN-γ), as well as antiinflammatory interleukin 1 receptor antagonist (IL-1Ra), interleukin 4 (IL-4), interleukin 10 (IL-10), and interleukin 13 (IL-13) cytokine expression and protein were increased in C57BL/6C mice, they were lower in immunocompromised mice. Although enkephalin, dynorphin, and β-endorphin messenger RNA expression also increased in C57BL/6C mice, peaking on day 14, this result was not observed in immunocompromised mice.
CONCLUSION: The contribution of inflammation to nerve injury is complex with biphasic modulation. During the early phase, a wide range of proinflammatory cytokines are released, leading to enhanced pain. In contrast, the analgesic effect of opioid peptides and antiinflammatory cytokines was more predominate in the later phases of injury, leading to attenuated pain responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307767     DOI: 10.1097/ALN.0b013e31820b8b1e

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  22 in total

Review 1.  Chemesthesis and the chemical senses as components of a "chemofensor complex".

Authors:  Barry G Green
Journal:  Chem Senses       Date:  2011-12-30       Impact factor: 3.160

Review 2.  Platelet-rich plasma and the elimination of neuropathic pain.

Authors:  Damien P Kuffler
Journal:  Mol Neurobiol       Date:  2013-07-07       Impact factor: 5.590

3.  Chronic morphine consumption increase allograft rejection rate in rat through inflammatory reactions.

Authors:  Ali Rafati; Sommaye Hamzehie Taj; Negar Azarpira; Assadollah Zarifkar; Ali Noorafshan; Parvaneh Najafizadeh
Journal:  Iran Biomed J       Date:  2011

4.  Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord.

Authors:  Cui'e Lu; Yue Liu; Bei Sun; Yu'e Sun; Bailing Hou; Yu Zhang; Zhengliang Ma; Xiaoping Gu
Journal:  Inflammation       Date:  2015-10       Impact factor: 4.092

Review 5.  The therapeutic potential of interleukin-10 in neuroimmune diseases.

Authors:  A J Kwilasz; P M Grace; P Serbedzija; S F Maier; L R Watkins
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

6.  Extracellular matrix hyaluronan signals via its CD44 receptor in the increased responsiveness to mechanical stimulation.

Authors:  L F Ferrari; D Araldi; O Bogen; J D Levine
Journal:  Neuroscience       Date:  2016-03-18       Impact factor: 3.590

7.  Fufang Kushen injection inhibits sarcoma growth and tumor-induced hyperalgesia via TRPV1 signaling pathways.

Authors:  Zhizheng Zhao; Huiting Fan; Tim Higgins; Jia Qi; Diana Haines; Anna Trivett; Joost J Oppenheim; Hou Wei; Jie Li; Hongsheng Lin; O M Zack Howard
Journal:  Cancer Lett       Date:  2014-09-19       Impact factor: 8.679

8.  Blocking the Spinal Fbxo3/CARM1/K+ Channel Epigenetic Silencing Pathway as a Strategy for Neuropathic Pain Relief.

Authors:  Tzer-Bin Lin; Hsien-Yu Peng; Ming-Chun Hsieh; Yu-Cheng Ho; Cheng-Yuan Lai; Hsueh-Hsiao Wang; Po-Sheng Yang; Jen-Kun Cheng; Gin-Den Chen; Soo-Cheen Ng; An-Sheng Lee; Kuang-Wen Tseng
Journal:  Neurotherapeutics       Date:  2021-01-07       Impact factor: 7.620

9.  The Inhibition of Spinal Astrocytic JAK2-STAT3 Pathway Activation Correlates with the Analgesic Effects of Triptolide in the Rat Neuropathic Pain Model.

Authors:  Jun Tang; Zhi-Hong Li; Shun-Nan Ge; Wei Wang; Xiao-Peng Mei; Wen Wang; Ting Zhang; Li-Xian Xu; Jin-Lian Li
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-29       Impact factor: 2.629

10.  Dry needling at myofascial trigger spots of rabbit skeletal muscles modulates the biochemicals associated with pain, inflammation, and hypoxia.

Authors:  Yueh-Ling Hsieh; Shun-An Yang; Chen-Chia Yang; Li-Wei Chou
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-23       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.